Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Erik L. Noach"'
Publikováno v:
European Journal of Pharmacology. 28:310-315
The influence of diphenylhydantoin (DPH) on intestinal glucose absoprtion was studied by perfusing an isolated jejunal loop of a rat under urethane anaesthesia. DPH produced dose dependent enhancement of glucose absorption. Since DPH also stimulates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de33f7f9c21b9a8d2f9edb0ed90baf8
https://doi.org/10.1016/0014-2999(74)90284-2
https://doi.org/10.1016/0014-2999(74)90284-2
Publikováno v:
Neurochemistry International. 12:203-208
It is still a matter of debate whether in dopaminergic nerve endings dopamine (DA) is present in different functional and/or metabolic compartments. To investigate this, DA metabolism was studied in vivo by measuring the specific activity of DA and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a72b1c2b440078acc8a65f1bc27b2b
https://doi.org/10.1016/0197-0186(88)90128-3
https://doi.org/10.1016/0197-0186(88)90128-3
Publikováno v:
European Journal of Pharmacology. 33:247-254
Two experiments were carried out in rats to investigate the mechanisms by which dopamine (DA) synthesis is regulated. First, a unilateral lesion was made in the substantia nigra, thus interrupting the nervous impulse flow of the nigro-striatal pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa82e6070da63dfd916db2d39917b66
https://doi.org/10.1016/0014-2999(75)90168-5
https://doi.org/10.1016/0014-2999(75)90168-5
Publikováno v:
Life Sciences. 28:973-981
Rats received 7 daily injections with baclofen (40 mg/kg), GBL (750 mg/kg) or HA-966 (100 mg/kg). Dopamine (DA) was measured in the striatum and olfactory tubercle (OT) of rats, sacrificed 0.5 h or 1 h after the last injection. Marked tolerance and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d9ea2779c51eb29e92053ff93e4526e
https://doi.org/10.1016/0024-3205(81)90742-6
https://doi.org/10.1016/0024-3205(81)90742-6
Publikováno v:
European Journal of Pharmacology. 60:153-161
Acute injections of HA-966 (100 mg/kg) into rats caused a rapid elevation of dopamine (DA) content in the striatum. 3,4-Dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels increased after a latency period of 0.5 h and 1 h respective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a853479e8f2361fd9360c47ac9d0c6c
https://doi.org/10.1016/0014-2999(79)90214-0
https://doi.org/10.1016/0014-2999(79)90214-0
Publikováno v:
European Journal of Pharmacology. 57:191-199
It is generally accepted that reserpine blocks the granular storage mechanism in catecholaminergic neurones and that (+)-amphetamine (AMP) releases dopamine (DA) from extragranular storage sites. In the present experiments it was investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a93951fa09c1199ca14a8c43eb121d8a
https://doi.org/10.1016/0014-2999(79)90365-0
https://doi.org/10.1016/0014-2999(79)90365-0
Autor:
F.C. Hillen, Erik L. Noach
Publikováno v:
European Journal of Pharmacology. 16:222-224
The effect of 1-hydroxy-3-amino-pyrrolidinone-2 (HA-966) on the concentrations of dopamine, noradrenaline and dopamine-metabolites in the rat corpus striatum was investigated. Intraperitoneal injection of HA-966 (100 mg/kg) increased the levels of do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2617200cb9f4aec3066a6311c170c97
https://doi.org/10.1016/0014-2999(71)90015-x
https://doi.org/10.1016/0014-2999(71)90015-x
Publikováno v:
The Journal of pharmacy and pharmacology. 32(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdc3e1e16bcfcf2488807a89a2f5800
https://pubmed.ncbi.nlm.nih.gov/6102135
https://pubmed.ncbi.nlm.nih.gov/6102135
Publikováno v:
European journal of pharmacology. 48(2)
Striatal dopamine (DA) of rats increased twofold 1 h after blockade of DA release by either an electrolytic lesion of the substantia nigra (SN) or systemic administration of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966). If the treatments were combined, n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367a8469e07abce3546eed351ce1901c
https://pubmed.ncbi.nlm.nih.gov/639847
https://pubmed.ncbi.nlm.nih.gov/639847
